Clinical Cancer Drugs

Editor-in-Chief

Giulio Francia
The University of Texas
El Paso, TX
(USA)

Personal Subscription
Become EABM
Become Reviewer



Meet Our Editor-in-Chief free to download

Volume:4   Issue: 1
Pp: 1-1
Giulio Francia*
DOI: 10.2174/2212697X0401170526184110



MicroRNA: A Multi-Facet Biological Target for Cancer and Other Diseases

Volume:4   Issue: 1
Pp: 2-9
Mahima Kaushik*, Swati Chaudhary, Swati Mahendru, Saami Ahmed, Ankit Kumar Pathak and Shrikant Kukreti
DOI: 10.2174/2212697X04666170123122037




Nitrogen Mustards: The Novel DNA Alkylator

Volume:4   Issue: 1
Pp: 10-46
Bhabesh Chandra Deka and Pradip Kr. Bhattacharyya*
DOI: 10.2174/2212697X04666170123120528




The PI3K/AKT/mTOR-Signal Transduction Pathway as Drug Target in Triple-Negative Breast Cancer

Volume:4   Issue: 1
Pp: 47-58
Jens C. Hahne*, Jorg B. Engel, Arnd Honig, Susanne R. Meyer, Domenico Zito, Andrea Lampis and Nicola Valeri
DOI: 10.2174/2212697X04666170321112629




Dexamethasone for the Prevention of Cisplatin-induced Ototoxicity

Volume:4   Issue: 1
Pp: 59-64
Ashley R. Popay, Daniel R. Lloyd, Mark N. Wass* and Martin Michaelis*
DOI: 10.2174/2212697X04666170331171359




Meningioma in an Elderly Presenting as Psychosis: A Case Report

Volume:4   Issue: 1
Pp: 65-68
Deepak Moyal* and Amit Garg
DOI: 10.2174/2212697X04666170331170942




Prevalence of Neuropathy Associated With Bortezomib: A Retrospective Study

Volume:4   Issue: 1
Pp: 69-72
Pulivarthi Swaroopa, Mathew Josy, Ehresmann Kirsten and Gurram Murali Krishna*
DOI: 10.2174/2212697X03666161128102453